Amvika Company Profile
What is the competitive landscape for AMVIKA
AMVIKA has five approved drugs.
Summary for Amvika
| US Patents: | 0 |
| Tradenames: | 5 |
| Ingredients: | 5 |
| NDAs: | 5 |
Drugs and US Patents for Amvika
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amvika | NEOMYCIN SULFATE | neomycin sulfate | TABLET;ORAL | 065220-001 | Jul 28, 2006 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Amvika | CLINDAMYCIN PHOSPHATE | clindamycin phosphate | GEL;TOPICAL | 211872-001 | Jul 29, 2020 | AB1 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Amvika | ESTRADIOL | estradiol | GEL;TRANSDERMAL | 217863-003 | Jul 12, 2024 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Amvika | ESTRADIOL | estradiol | GEL;TRANSDERMAL | 217863-002 | Jul 12, 2024 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
